Document is current
Any future updates will be listed below
-
Authors
Liemburg, Edith
Sibeijn-Kuiper, Anita
Bais, Leonie
Pijnenborg, Gerdina
Knegtering, Henderikus
van der Velde, Jorien
Opmeer, Esther
de Vos, Annerieke
Dlabac-De Lange, Jozarni
Wunderink, Lex
Aleman, André
- License Information
-
More Information
Article History
Received: 26 October 2015
Accepted: 2 February 2016
First Online: 23 February 2016
Competing interests
: All authors declare that there are no competing financial interests in relation to the work described. Henderikus Knegtering, MD, PhD is on the speakers list of and/or has received unconditional grants from Janssen, Eli Lilly, Bristol Meyers Squibb, Astra Zeneca and Eli Lilly. Lex Wunderink received a fee from Takeda for an advisory board meeting. André Aleman received speaker fees from Lundbeck.
